SUNNYVALE, Calif., Oct. 29,
2024 /PRNewswire/ -- Ceribell, Inc. (Nasdaq:
CBLL) ("Ceribell"), a commercial-stage medical technology company
focused on transforming the diagnosis and management of patients
with serious neurological conditions, today announced that it will
release financial results for the third quarter of 2024 after the
close of trading on Tuesday, November 12,
2024. Company management will host a conference call to
discuss financial results beginning at 1:30
p.m. PT / 4:30 p.m. ET.
Investors interested in listening to the conference call may do
so by dialing (800) 715-9871 for domestic callers or (646) 307-1963
for international callers and providing access code 7168007. A live
and archived webcast of the event will be available in the
"Investor Relations" section of the Ceribell website
at https://investors.ceribell.com/.
About Ceribell Inc.
Ceribell is a commercial-stage
medical technology company focused on transforming the diagnosis
and management of patients with serious neurological conditions.
The Ceribell System is an AI-powered, rapidly deployable
point-of-care electroencephalography ("EEG") platform designed to
address the unmet needs of patients in the acute care setting. The
company is headquartered in Sunnyvale,
Calif.
Investor Contact
Brian
Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com
Media Contact
Corrie
Rose
Press@ceribell.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ceribell-to-report-third-quarter-2024-financial-results-on-november-12-2024-302290488.html
SOURCE Ceribell, Inc.
